Overview
mRNA technology could be key to tackling cancer, respiratory diseases and latent viruses, says Moderna’s Stéphane Bancel.

Related insights

Investment trusts: two paths to growth
Two investment trusts, two routes to long-term growth through patience, conviction and resilience.April 2026
Article|11 minutes
Cultivating uncertainty
We can’t know which AI companies will bloom, but Anthropic’s culture inspires confidence.April 2026
Article|5 minutes
Sea surge
Gaming, ecommerce, fintech: why Singapore’s Sea Ltd is a success story.April 2026
Article|6 minutes

